192 related articles for article (PubMed ID: 9734710)
1. Endothelin converting enzyme inhibitor protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension.
Takahashi T; Kanda T; Inoue M; Sumino H; Kobayashi I; Iwamoto A; Nagai R
Life Sci; 1998; 63(10):PL137-43. PubMed ID: 9734710
[TBL] [Abstract][Full Text] [Related]
2. Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Takahashi T; Kanda T; Imai S; Suzuki T; Kobayashi I; Nagai R
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):17-32. PubMed ID: 8824928
[TBL] [Abstract][Full Text] [Related]
3. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
4. A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Takahashi T; Kanda T; Inoue M; Suzuki T; Kobayashi I; Kodama K; Nagai R
Life Sci; 1996; 59(23):PL 371-7. PubMed ID: 8950302
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of drag-reducing polymers in a rat model of monocrotaline-induced pulmonary hypertension.
Wang Y; Hu F; Mu X; Wu F; Yang D; Zheng G; Sun X; Gong K; Zhang Z
Biorheology; 2016 Jan; 53(1):13-22. PubMed ID: 26889655
[TBL] [Abstract][Full Text] [Related]
7. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
8. Semotiadil inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Takahashi T; Kanda T; Imai S; Suzuki T; Kobayashi I; Murata K
Cardiovasc Drugs Ther; 1995 Dec; 9(6):809-14. PubMed ID: 8850386
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
10. Monocrotaline-induced structural remodeling of the intra-acinar pulmonary arteries and pulmonary hypertension.
Li WY; Che DY
J Tongji Med Univ; 1992; 12(4):227-33. PubMed ID: 1289571
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of hepatocyte growth factor with prostacyclin synthase in severe pulmonary hypertension of rats.
Ono M; Sawa Y; Fukushima N; Suhara H; Nakamura T; Yokoyama C; Tanabe T; Matsuda H
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1092-7. PubMed ID: 15541968
[TBL] [Abstract][Full Text] [Related]
12. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline.
Yoshihara F; Nishikimi T; Horio T; Yutani C; Takishita S; Matsuo H; Ohe T; Kangawa K
Eur J Pharmacol; 1998 Aug; 355(1):33-9. PubMed ID: 9754936
[TBL] [Abstract][Full Text] [Related]
13. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
Rakotoniaina Z; Guerard P; Lirussi F; Rochette L; Dumas M; Goirand F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):241-51. PubMed ID: 18542928
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effect of cerium oxide nanoparticles in monocrotaline rat model of pulmonary hypertension: A possible implication of endothelin-1.
Nassar SZ; Hassaan PS; Abdelmonsif DA; ElAchy SN
Life Sci; 2018 May; 201():89-101. PubMed ID: 29588134
[TBL] [Abstract][Full Text] [Related]
16. Sandostatin inhibits development of medial proliferation of pulmonary arteries in a rat model of pulmonary hypertension.
Takahashi T; Kanda T; Imai S; Suzuki T; Murata K
Life Sci; 1995; 57(8):PL91-5. PubMed ID: 7637546
[TBL] [Abstract][Full Text] [Related]
17. Effect of small hairpin RNA targeting endothelin-converting enzyme-1 in monocrotaline-induced pulmonary hypertensive rats.
Son JS; Kim KC; Kim BK; Cho MS; Hong YM
J Korean Med Sci; 2012 Dec; 27(12):1507-16. PubMed ID: 23255850
[TBL] [Abstract][Full Text] [Related]
18. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
19. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
20. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
Liu H; Liu ZY; Guan Q
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
